SHP674

pegaspargase · Institut de Recherches Internationales Servier

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHP674, covering 2022-06-10 to 2022-06-10. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of SHP674 (Pegaspargase) in Participants With Newly Diagnosed, Untreated Acute Lymphoblastic Leukemia [Phase 2]

See pricing